✦ LIBER ✦

Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function

✍ Scribed by Rafael Morales-Barrera; Joaquim Bellmunt; Cristina Suárez; Claudia Valverde; Marta Guix; Cesar Serrano; Manuel Gallén; Joan Carles

Book ID: 116431109
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 336 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2012.04.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Feasibilty study of gemcitabine and cisp

Feasibilty study of gemcitabine and cisplatin administered every two weeks in patients with advanced urothelial tumors and impaired renal function

✍ Joan Carles; Cristina Suárez; Carlos Mesía; Miquel Nogué; Albert Font; Montserra 📂 Article 📅 2006 🏛 Springer Milan 🌐 Spanish ⚖ 310 KB

Phase II trial of dose-dense doxorubicin

Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal function

✍ Matthew D. Galsky; Alexia Iasonos; Svetlana Mironov; Joseph Scattergood; Mary G. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 1 views

Re: Final results of sequential doxorubi

Re: Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium

✍ Christopher J. Logothetis; Arlene Siefker-Radtke 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 98 KB